Skip to main content
. 2018 Feb 16;13(2):e0192881. doi: 10.1371/journal.pone.0192881

Fig 2. Survival analysis for ARID1A.

Fig 2

Survival was better for the subgroup of patients with ARID1A positive tumors (N = 27) compared to the subgroup with ARID1A negative tumors (N = 70).